Nongnit Laytragoon Lewin1, Jan-Erik Karlsson2,3, David Robinsson4, Matida Fagerberg4, Magnus Kentsson2, Shariel Sayardoust5, Mats Nilsson6,7, Levar Shamoun1, Bengt-Åke Andersson1, Sture Löfgren1, Lars Erik Rutqvist8, Freddi Lewin9. 1. Dept Laboratory Medicine, Ryhov Hospital, Jönköping, Sweden. 2. Dept of Internal Medicine, Ryhov Hospital, Jönköping, Sweden. 3. Dept of Health Medicine and Caring Sciences, Linköping University, Linköping, Sweden. 4. Dept Urology, Ryhov Hospital, Jönköping, Sweden. 5. Dept Periodontology, Ryhov Hospital, Jönköping, Sweden. 6. Futurum, Academy of Health and Care, Region Jönköping, Jönköping, Sweden. 7. Dept Medical and Health Sciences, Linköping University, Linköping, Sweden. 8. Scientific Affairs Group, Swedish Match AB, Stockholm, Sweden. 9. Dept Oncology, Ryhov Hospital, Jönköping, Sweden.
Abstract
INTRODUCTION: Cigarette smoke is suggested to be a risk factor for coronary artery disease (CAD), urinary bladder cancer (UBCa) or lung cancer (LCa). However, not all heavy smokers develop these diseases and elevated cancer risk among first-degree relatives suggests an important role of genetic factor. METHODS: Three hundred and ten healthy blood donors (controls), 98 CAD, 74 UBCa and 38 LCa patients were included in this pilot study. The influence of 92 single nucleotide polymorphisms (SNPs) and impact of cigarette smoking were analysed. RESULTS: Out of 92 SNPs tested, differences in distribution of 14 SNPs were detected between controls and patient groups. Only CTLA4 rs3087243 showed difference in both CAD and UBCa patient group compared to control group. Stratified by smoking status, the impact of smoking was associated to frequencies of 8, 3 and 4 SNPs in CAD, UBCa, LCa patients, respectively. None of these 92 SNPs showed a statistically significant difference to more than one type of disease among smoking patients. In non-smoking patients, 7, 3 and 6 SNPs were associated to CAD, UBCa, LCa, respectively. Out of these 92 SNPs, CTLA4 rs3087243 was associated to both non-smoking CAD and UBCa. The XRCC1 rs25487 was associated to both non-smoking UBCa and LCa. CONCLUSION: SNPs might be important risk factors for CAD, UBCa and LCa. Distribution of the SNPs was specific for each patient group, not a random event. Impact of cigarette smoking on the disease was associated to the specific SNP sequences. Thus, smoking individuals with SNPs associated to risk of these serious diseases is an important target group for smoking cessation programs.
INTRODUCTION: Cigarette smoke is suggested to be a risk factor for coronary artery disease (CAD), urinary bladder cancer (UBCa) or lung cancer (LCa). However, not all heavy smokers develop these diseases and elevated cancer risk among first-degree relatives suggests an important role of genetic factor. METHODS: Three hundred and ten healthy blood donors (controls), 98 CAD, 74 UBCa and 38 LCapatients were included in this pilot study. The influence of 92 single nucleotide polymorphisms (SNPs) and impact of cigarette smoking were analysed. RESULTS: Out of 92 SNPs tested, differences in distribution of 14 SNPs were detected between controls and patient groups. Only CTLA4rs3087243 showed difference in both CAD and UBCa patient group compared to control group. Stratified by smoking status, the impact of smoking was associated to frequencies of 8, 3 and 4 SNPs in CAD, UBCa, LCapatients, respectively. None of these 92 SNPs showed a statistically significant difference to more than one type of disease among smoking patients. In non-smoking patients, 7, 3 and 6 SNPs were associated to CAD, UBCa, LCa, respectively. Out of these 92 SNPs, CTLA4rs3087243 was associated to both non-smoking CAD and UBCa. The XRCC1rs25487 was associated to both non-smoking UBCa and LCa. CONCLUSION: SNPs might be important risk factors for CAD, UBCa and LCa. Distribution of the SNPs was specific for each patient group, not a random event. Impact of cigarette smoking on the disease was associated to the specific SNP sequences. Thus, smoking individuals with SNPs associated to risk of these serious diseases is an important target group for smoking cessation programs.
Authors: W P Bennett; M C Alavanja; B Blomeke; K H Vähäkangas; K Castrén; J A Welsh; E D Bowman; M A Khan; D B Flieder; C C Harris Journal: J Natl Cancer Inst Date: 1999-12-01 Impact factor: 13.506
Authors: Gerd P Pfeifer; Mikhail F Denissenko; Magali Olivier; Natalia Tretyakova; Stephen S Hecht; Pierre Hainaut Journal: Oncogene Date: 2002-10-21 Impact factor: 9.867
Authors: Cristina Canova; Mia Hashibe; Lorenzo Simonato; Mari Nelis; Andres Metspalu; Pagona Lagiou; Dimitrios Trichopoulos; Wolfgang Ahrens; Iris Pigeot; Franco Merletti; Lorenzo Richiardi; Renato Talamini; Luigi Barzan; Gary J Macfarlane; Tatiana V Macfarlane; Ivana Holcátová; Vladimir Bencko; Simone Benhamou; Christine Bouchardy; Kristina Kjaerheim; Ray Lowry; Antonio Agudo; Xavier Castellsagué; David I Conway; Patricia A McKinney; Ariana Znaor; Bernard E McCartan; Claire M Healy; Manuela Marron; Paul Brennan Journal: Cancer Res Date: 2009-04-01 Impact factor: 12.701